Tag: CHKE

Blue Horseshoe Stocks: CHKE Recap, Options Ideas & More

Cherokee, Inc. CHKE – Update

We flagged CHKE yesterday as a stock we felt was undervalued coming off of a particularly rough month that saw it get beaten back to new 52-week lows. Our ‘bottom-feeding’ sense immediately kicked in, and in a timely fashion at that. The stock did indeed exhibit the early signs of a recovery, registering higher lows than the session prior, and making a modest move up from 14.67-15.83 (+8%).

We’re going to want to continue to track CHKE for the possibility of a protracted rebound (Remember, there is also a massive gap to fill on the chart), and in that event we’ll be looking to possibly take advantage using the CHKE options chain. We’ll look at the only contracts that had open interest yesterday, which were the 10/16 $17.50 Calls (Last Trade: .30).

If CHKE were to regain even half of the ground lost between its current PPS and that of a month ago, those calls will be pushed deep into the money, and would provide us with a chance to profit tidily.

Santo Mining Corp. SANP

SANP is a super-subpenny play we flagged for observation on Monday, and it didn’t take very long for us to observe a nice move from the stock. Following a low of .0003 on Tuesday, SANP has made a good intraweek swing of 133%, trading as high as .0007 yesterday on volume which exceeded the monthly average volume by six times.

There really wasn’t a heck of a lot going on with this play prior to the beginning of this month, and this weeks activity has come on the heels of the company securing a new Chief Market Officer with an impressive resume, so we’ll be interested to follow along and see what he has in store in the way of changes for SANP.

___

Added Note:

Speaking of super-subpennies, Embarr Downs, Inc. EMBR has caught our eye this morning as a play that bounced off of its 52-week low and made a brief move into subpenny territory yesterday. We’ll have this one on watch as well, in case further action provides a chance for quick intraday strikes.

Extended Watchlist:
AERI, CVC, SIRG, GTSO,
BGMD(Bottom-Watch)

Blue Horseshoe Stocks: EQLB, TPIV, CHKE & More


EQ Labs, Inc. EQLB

EQLB was the big standout from yesterday’s report, performing extremely well after receiving first-billing in our premarket extended watchist. We caught this momentum play on an early scan and were very pleased to have included a mention of the stock as it blasted off right out of the starting gate.

From an initial low of .0035, EQLB surged as high as .0062 for a very respectable 77% intraday rip on excessive volume; it traded its one month average ten times over. It and our next mention accounted for two of the top three most-actively traded stocks on the OTC, so we were certainly poking our noses in the right place.

With momentum carrying over from the previous session to yesterday, moving forward, we’ll be open two the possibilities of either a sustained uptrend, or a potential dip-and-rip scenario.

TapImmune, Inc. TPIV

Our other nice spot from yesterday’s report was TPIV, which caught our eye in the wake of an early PR relating to one of its vaccine’s inclusion in a USDOD-funded study.

We had already been following the stock all summer; regular readers will recall our tracking this play to double-bag gains back in June. That history, the press, and a ripening chart more-than warranted another mention, and it turned out well. TPIV ran from an early low of .52, and steadily rose toward its HOD of .68, marking a 31% increase.

We’ll certainly continue to monitor its progress, especially given the fact that it maintained nearly all of its daily advances, closing just a penny off of the high at .67.

Cherokee, Inc. CHKE

Our readers are well aware of our penchant for bargain hunting, and we’ve got a potential bottom-watch candidate in CHKE to bring to the table today. The stock recently underwent a huge gap-down as a result of poorly-received earnings, and on Monday, was been beaten back to its annual lows.

That sort of activity always draws our attention, and in this case, the snap-back could be quite significant with a huge gap to fill on the chart. Add in analyst price targets ranging from $21-33, and this play begins to look out of place at such a low PPS. We’ll be scanning this one continuously for signs of recovery.

Extended Watchlist:
ITCI, ADEC, TOVC, GROC